Page results
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
Information about our UCLH Charity, charity funds and associated charities.
-
UCLH will play a vital role in a new respiratory virus study.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
This page explains the Rafaelo™ procedure, a treatment for haemorrhoids, which are also known as piles.
File results
-
FOI/2023/0653 - Telecommunication pay as you go contract
-
FOI/2023/0654 - Email encryption/ E-signature suppliers
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0658 - Policies/procedures for Non-emergency patient transport services
-
FOI/2023/0662 - NEPTS and patient transport services
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier